CoV-Sym: The development of a psychometrically validated patient reported outcome measure for COVID-19
C. Lythgoe (Liverpool, United Kingdom), A. Rowe (Liverpool, United Kingdom), O. Aiyegbusi (Birmingham, United Kingdom), L. Chambers (Liverpool, United Kingdom), F. Sherratt (Liverpool, United Kingdom), J. Wood (Liverpool, United Kingdom), B. Young (Liverpool, United Kingdom), D. Wootton (Liverpool, United Kingdom)
Source: International Congress 2022 – COVID complications
Session: COVID complications
Session type: Thematic Poster
Number: 412
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Lythgoe (Liverpool, United Kingdom), A. Rowe (Liverpool, United Kingdom), O. Aiyegbusi (Birmingham, United Kingdom), L. Chambers (Liverpool, United Kingdom), F. Sherratt (Liverpool, United Kingdom), J. Wood (Liverpool, United Kingdom), B. Young (Liverpool, United Kingdom), D. Wootton (Liverpool, United Kingdom). CoV-Sym: The development of a psychometrically validated patient reported outcome measure for COVID-19. 412
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|